What is the current price / NAV of ITI Pharma & Healthcare Fund(IDCW)?
The current NAV of ITI Pharma & Healthcare Fund(IDCW) is ₹18.14, as of 15th July 2025.What are the returns of ITI Pharma & Healthcare Fund(IDCW)?
The ITI Pharma & Healthcare Fund(IDCW) was launched on 8th November 2021. This mutual fund's past returns are as follows:- 1 Year Returns: 16.18%
- 3 Year Returns: 25.33%
What are the top 5 sectoral holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top sectors ITI Pharma & Healthcare Fund(IDCW) has invested in are as follows:- Pharmaceuticals | 69.49%
- Labs & Life Sciences Services | 21.67%
- Others | 4.03%
- Fertilizers & Agro Chemicals | 2.58%
- Diversified Chemicals | 1.33%
What are the top 5 holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top 5 holdings for ITI Pharma & Healthcare Fund(IDCW) are as follows:- Sun Pharmaceutical Industries Ltd | 11.99%
- Divi's Laboratories Ltd | 9.03%
- Max Healthcare Institute Ltd | 6.12%
- Apollo Hospitals Enterprise Ltd | 5.35%
- Lupin Ltd | 5.13%
What is the asset allocation of ITI Pharma & Healthcare Fund(IDCW)?
The asset allocation for ITI Pharma & Healthcare Fund(IDCW) is as follows:- Equity | 97.26%
- Cash & Equivalents | 2.74%
What is the AUM of ITI Pharma & Healthcare Fund(IDCW)?
The AUM (i.e. assets under management) of ITI Pharma & Healthcare Fund(IDCW) is ₹229.93 Cr as of 15th July 2025.What is the expense ratio of ITI Pharma & Healthcare Fund(IDCW)?
The expense ratio of ITI Pharma & Healthcare Fund(IDCW) Plan is 0.47 as of 15th July 2025.What is the alpha ratio of ITI Pharma & Healthcare Fund(IDCW)?
The alpha ratio for the ITI Pharma & Healthcare Fund(IDCW) is 2.99
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of ITI Pharma & Healthcare Fund(IDCW)?
The volatility or standard deviation for the ITI Pharma & Healthcare Fund(IDCW) is 16.53
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sharpe ratio for the ITI Pharma & Healthcare Fund(IDCW) is 0.68
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sortino Ratio for the ITI Pharma & Healthcare Fund(IDCW) is 0.07
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of ITI Pharma & Healthcare Fund(IDCW)?
The PE ratio of ITI Pharma & Healthcare Fund(IDCW) is 62.20, while category PE ratio is 58.82.
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%